US EditionTrump order directs federal agencies to reclassify marijuana from Schedule I to Schedule III, reshaping federal drug policy
The order aims to increase medical cannabis research and access to CBD products while maintaining federal illegality of recreational marijuana, with 82% public support, Trump said.
- On Dec. 18, President Donald Trump signed an executive order in the Oval Office to reschedule marijuana from Schedule I to Schedule III with `Today, I'm pleased to announce that I will be signing an executive order to reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses`, Trump said.
- Since 1970, marijuana was classified as Schedule I with no accepted medical use, while President Joe Biden's review and a 2024 proposed rescheduling rule stalled.
- Industry groups say rescheduling could lower tax burdens, ease banking, and expand research access, while premarket trading showed Tilray shares up nearly 5% and SNDL rising 3%.
- The order directs Attorney General Pam Bondi to hasten rescheduling without a timeline, officials stressed it "is not the legalization" and asks aides to work with Congress and HHS on CBD access and Medicare CBD pilot consideration.
- Advocates welcomed the order and said it enables evidence-based discussions, while Nash County Sheriff Keith Stone raised safety concerns and Florida's 2024 ballot initiative failed despite nearly 56% support.
349 Articles
349 Articles
Trump Loosens Curbs on Marijuana, Encourages Research
Get latest articles and stories on World at LatestLY. The move on Thursday requires Attorney General Pam Bondi to expedite the process under the Drug Enforcement Administration for reclassifying marijuana. World News | Trump Loosens Curbs on Marijuana, Encourages Research.
What the marijuana policy shift means for cannabis research
President Trump signed an executive order reclassifying the federal status of marijuana, categorizing it as a drug with less potential for harm and dependence. It's a major shift in policy that could have wide-ranging effects on cannabis use and research. William Brangham discussed more with Beau Kilmer of the RAND Drug Policy Research Center.
Trump Just Gave a Handout to Big Marijuana
President Donald Trump signed an executive order today that committed the Justice Department to “rescheduling” marijuana. Although the order won’t legalize pot, it will relax a series of restrictions that the federal government has long enforced. The move has a broad coalition of supporters, including many progressives, who say that it will enable medical research and alleviate mass incarceration. But in reality, rescheduling marijauna will do l…
Washington.- President Donald Trump signed on Thursday an executive order that could reclassify marijuana as a less dangerous drug and open up new avenues for medical research, a major change in federal drug policy that is closer to what many states have done. The change would remove marijuana from its current classification as a drug on List I, along with heroin and LSD. Instead, cannabis would be a substance on List III, such as ketamine and s…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
